The global Clinical Genomics market is expected to reach USD 1826.11 million by 2028. Clinical Genomics market report provides crucial industry insights th
The North Carolina Clinical Genomic Evaluation by Next-gen Exome Sequencing, 2 (NCGENES 2) study is part of a larger consortium project investigating the clinical utility, or net benefit of an interve
Genome sequencing of virus has become an unavoidable tool for the better understanding of virus pathogenecity and epidemiological surveillance. However to sequence virus genome directly from clinical
Additional file 1: Odds of Pathogenicity (OddsPath) by performance of classified variant controls. Contains two tables modeling the Odds of Pathogenicity and strength of evidence based on the number o
Additional file 1. List of variants subjected to structural analysis, with details of protein modelling, effects observed and contribution of evidence to final variant classification.
